IGWM
FLNA

ICA Group Wealth Management’s Filana Therapeutics FLNA Stock Holding History

ICA Group Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50
Closed -$1.21K – 1398
2023
Q1 		$1.21K Hold
50
– – ﹤0.01% 1138
2022
Q4 		$1.48K Buy
+50
New +$1.8K ﹤0.01% 1142

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ICA Group Wealth Management's FLNA Position: Q2 2023 in Review

ICA Group Wealth Management sold out of Filana Therapeutics (FLNA) in Q2 2023, closing a stake of 50 shares — an estimated $1.21K sold.

ICA Group Wealth Management first reported a position in FLNA in Q4 2022 and held it in 2 quarters. The position peaked at $1.48K in Q4 2022. 152 funds tracked by Wall St. Rank hold FLNA as of Q2 2023.

  • ICA Group Wealth Management reported no remaining Filana Therapeutics position as of Q2 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 50 Filana Therapeutics shares in Q2 2023, an estimated $1.21K.
  • ICA Group Wealth Management first reported a position in Filana Therapeutics in Q4 2022 and held it in 2 quarters.
  • ICA Group Wealth Management's Filana Therapeutics position peaked at $1.48K in Q4 2022.
  • 152 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2023.

Based on ICA Group Wealth Management's 13F filing for Q2 2023, filed 11 Aug 2023.